Glaxo invests half a billion pounds in Indian consumer healthcare division

Pharmaceuticals group GlaxoSmithKline (GSK) has upped its stake in its Indian consumer healthcare subsidiary by investing over half a billion pounds in the unit.

Pharmaceuticals group GlaxoSmithKline (GSK) has upped its stake in its Indian consumer healthcare subsidiary by investing over half a billion pounds in the unit.

GSK, which first announced an open offer back in November, has now raised its stake in the Indian publicly-listed division from 43.2% to 72.5% in an effort to raise its exposure to a "key emerging market", according to the company's Chief Strategy Officer David Redfern.

The offer period (January 17th-30th) saw shareholders in GSK Consumer Healthcare Ltd validly tender 12,319,749 shares representing 29.3% of the total shares outstanding.

The offer of INR3,900 per share values the deal at INR48bn, around £568m.

Redfern said: "We are very pleased with the outcome of this transaction, which will further increase our exposure to a key emerging market.

"It is a significant vote of confidence in the long-term growth prospects of our Consumer Healthcare business in India."

Recommended

Share tips of the week – 15 October
Share tips

Share tips of the week – 15 October

MoneyWeek’s comprehensive guide to the best of this week’s share tips from the rest of the UK's financial pages.
15 Oct 2021
Trading: stash the family cash in this cheap wealth management firm
Trading

Trading: stash the family cash in this cheap wealth management firm

Wealth management is a growth market. Rathbone Brothers should be a prime beneficiary – and looks cheap. Matthew Partridge explains the best way to pl…
12 Oct 2021
What the best-performing investment trusts of the past 20 years can teach us
Investment trusts

What the best-performing investment trusts of the past 20 years can teach us

Forty-two trusts have risen more than tenfold over the last two decades. What made the winners stand out? And how can we identify future outperformers…
12 Oct 2021
Activision Blizzard: a cheap play on videogames
Share tips

Activision Blizzard: a cheap play on videogames

Videogame maker Activision Blizzard has been in the news for the wrong reasons lately. But it has a bright future, says Stephen Connolly.
11 Oct 2021

Most Popular

How to invest in SMRs – the future of green energy
Energy

How to invest in SMRs – the future of green energy

The UK’s electricity supply needs to be more robust for days when the wind doesn’t blow. We need nuclear power, says Dominic Frisby. And the future of…
6 Oct 2021
Inflation is still one of the biggest threats to your personal finances
Investment strategy

Inflation is still one of the biggest threats to your personal finances

Central bankers and economists insist inflation will be gone by next year. We're not so sure, says Merryn Somerset Webb. So if you haven’t started to …
1 Oct 2021
How to invest as we move to a hydrogen economy
Energy

How to invest as we move to a hydrogen economy

The government has started to roll out its plans for switching us over from fossil fuels to hydrogen and renewable energy. Should investors buy in? St…
8 Oct 2021